Muscular Dystrophy (MD) / Stem Cell Therapy

Unique Access provides access to an extensive treatment protocol for Muscular Dystrophy which uses higher quantities of stem cells, extensive rehabilitation, and many supportive therapies. This effective combination of the most advanced medical technologies, with systematic physical and occupational therapies, has helped previously treated patients achieve a broad range of important improvements.

Muscular Dystrophy (MD) is a group of inherited progressive muscle disorders which are characterised by muscle weakness, wasting and degeneration. Some forms of Muscular Dystrophy (MD) can also affect other body organs such as heart, gastrointestinal tract and the brain. Muscular Dystrophy (MD) are caused by mutations in genes that code for specific muscle proteins.

Duchenne Muscular Dystrophy (DMD) is one of the most common and lethal Muscular Dystrophys which affects 1 in every 3,500 males and is caused by mutations in the dystrophin gene. Dystrophin is a critical component of the Dystrophin Glycoprotein Complex (DGC), which is involved in stabilising interactions between the sarcolemma, the cytoskeleton, and the extracellular matrix of skeletal and cardiac muscles. There are many other kinds of Muscular Dystrophies (MDs), including Becker’s Muscular Dystrophy, Limb Girdle Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy, etc.

Duchenne Muscular Dystrophy (DMD) patients characteristically display progressive muscle weakness, which begins in early childhood. Although Duchenne Muscular Dystrophy (DMD) is present at birth, clinical symptoms are not evident until 3-5 years of age.

Initial symptoms of the illness include leg weakness, increasing convex curvature of the spine, and a waddle-like gait. Continuous muscle-wasting results in progressively weaker muscles, usually leaving DMD patients wheelchair-bound by the age of 11 or 12.

In the latter stages, most patients succumb to cardiac or respiratory failure in their twenties, although rare cases of survival into the thirties have been reported . A similar, yet milder, dystrophy known as Becker Muscular Dystrophy (BMD) is more variable phenotypically and generally follows a less severe course than Duchenne Muscular Dystrophy (DMD). Other types are generally adult onset and are comparatively slowly progressive.